PathoQuest
2024 Revenue
$5.9M
Funding
$24.1M
YOY
46.1%
Team
56
Founded
2010
How PathoQuest CEO Jean François Brepson grew PathoQuest to $5.9M revenue with a 56 person team in 2024.
Developer of a molecular diagnostics technology designed to improve pathogen detection in biological samples. The company's technology combines sample preparation technology and cloud-based bioinformatics which is applicable to several types of samples with a proprietary pathogen genome sequence database and automated analysis pipeline, enabling doctors to improve the breadth of pathogen detection.
Last updated
PathoQuest Revenue
In 2024, PathoQuest's revenue reached $5.9M. The company previously reported $4M in 2023. Since its launch in 2010, PathoQuest has shown consistent revenue growth.
| Year | Milestone |
|---|---|
| 2024 | PathoQuest Hit $5.9m revenue in October 2024 |
| 2023 | PathoQuest Hit $4m revenue in October 2023 |
| 2021 | PathoQuest Hit $3.1m revenue in April 2021 |
| 2010 | Launched with $0 revenue |
PathoQuest Valuation, Funding Rounds
PathoQuest has not publicly disclosed its valuation. The company has raised $24.1M in total funding to date.
PathoQuest has raised $24.1M in total funding across 5 rounds, with its most recent round in 2019.
| Year | Round | Amount | Valuation | % Sold |
|---|---|---|---|---|
| 2019 | Funding round | $9.8M | - | - |
| 2018 | Funding round | $4.9M | - | - |
| 2015 | Funding round | $2.4M | - | - |
| 2013 | Funding round | $4.6M | - | - |
| 2011 | Funding round | $2.4M | - | - |
PathoQuest Employees & Team Size
PathoQuest employs approximately 56 people as of 2026, up from 47 in 2023.
PathoQuest has 56 total employees in different roles and functions and 1 sales reps that carry a quota.
| Year | Milestone |
|---|---|
| 2024 | Reached 56 employees (December 2024) |
| 2024 | Reached 47 employees (October 2024) |
| 2023 | Reached 47 employees (October 2023) |
| 2022 | Reached 51 employees (October 2022) |
| 2021 | Reached 44 employees (December 2021) |
| 2021 | Reached 36 employees (April 2021) |
Founder / CEO
Jean François Brepson
Jean-François Brepson has over 20 years leadership experience in the Pharmaceutical Industry. Prior to joining PathoQuest, Mr. Brepson was a Senior Vice-President at IPSEN where he was responsible for leading the global GI-Oncology & Endocrinology Franchise. He made a decisive contribution to the creation of leading portfolio in Neuro-EndocrineTumors in close collaboration with R&D and Business Development teams. He led the pre-launch of IPSEN first product in GI-Oncology on a worldwide basis. Prior to this, Mr. Brepson held several commercial operations positions at IPSEN including area Manager, BU Head, and General Manager in the EMEA region. Mr. Brepson has an Engineering Degree in Data Management System and a Master Degree in Foreign Trade. He has also earned "The Leadership & Innovation Certificate" for HEC in Paris and "The Blue Ocean Strategy Certificate" from INSEAD in Fontainebleau.
Q&A
| Question | Answer |
|---|---|
| What's your age? | - |
| Favorite online tool? | - |
| Favorite book? | - |
| Favorite CEO? | - |
| Advice for 20 year old self | - |
Customers
We do not have customer count information for PathoQuest yet.
Frequently Asked Questions about PathoQuest
What is PathoQuest's revenue?
PathoQuest generates $5.9M in revenue.
Who founded PathoQuest?
PathoQuest was founded by Jean François Brepson.
Who is the CEO of PathoQuest?
The CEO of PathoQuest is Jean François Brepson.
How much funding does PathoQuest have?
PathoQuest raised $24.1M.
How many employees does PathoQuest have?
PathoQuest has 56 employees.
Where is PathoQuest headquarters?
PathoQuest is headquartered in Paris, Ile-de-france, France.
People Also Viewed
Zeal
Modern payroll for modern work
treble.ai
Treble.ai is an internet based company.
Resend
Email for developers
LawRank
SEO company for lawyers specializing in organic SEO, PPC and web design helping clients rank for competitive, high-traffic keywords
Echobox
Developer of an artificial intelligence platform intended to help online publishers to share content on social media. The company's platform helps news publishers to maximize their reach on social media by detecting viral content and giving suggestions on which articles to share on social networks at specific times, enabling clients to increase sale and save time.
Graft
Graft is a cloud-native platform that empowers everyone in your organization to wield the most advanced AI techniques to unlock the value of text, images, video, audio, and graphs. No machine learning skills required, no team to hire, and no infrastructure to build or maintain.
Source Attribution
Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.
Company data last updated .